Ubie, Inc., a Tokyo, Japan-based healthcare startup, raised additional $19m and closed its Series C round at $45m.
The extension round was raised from Sogo Medical CO., LTD., AAIC Investment Pte. Ltd., Japan Impact Investment II Limited Partnership, and Rakuten Capital, while loans extended from the Shoko Chukin Bank, Ltd., Japan Finance Corporation, and Mizuho Bank, Ltd. Read here about the previous close.
The company, which has raised $76m in total funding, intends to use the capital to accelerate its growth and strengthen its presence in the U.S.
Ubie aims at “guiding people to appropriate medical care with technology.” With AI as its core technology, the company provides an AI symptom checker as the gateway to medical care. Leveraging the Series C funding, Ubie established a local subsidiary in New York on October 4, 2022. This is the second overseas corporation following Singapore.
Ryusuke Shigetomi, Chairman and Representative Director of Blackstone Group Japan, was appointed as a Ubie board member as an outside director to strengthen the company’s management structure and governance. In 1984, he graduated from the University of Tokyo, Faculty of Law, and joined Industrial Bank of Japan. In 2000, he joined Morgan Stanley, where he was responsible for the Telecom, Media, and Technology Group in Japan and assisted in the execution of various large-scale financing projects and M&A transactions for 22 years. In 2021, he joined the Blackstone Group, where he served as Chairman and Representative Director and was involved in investment and fundraising activities in Japan.
FinSMEs
08/12/2022